.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cipla
Covington
Julphar
Colorcon
Cantor Fitzgerald
AstraZeneca
Mallinckrodt
Medtronic
Daiichi Sankyo

Generated: December 12, 2017

DrugPatentWatch Database Preview

OPTICROM Drug Profile

« Back to Dashboard

Which patents cover Opticrom, and when can generic versions of Opticrom launch?

Opticrom is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in OPTICROM is cromolyn sodium. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
Drug patent expirations by year for OPTICROM

Medical Subject Heading (MeSH) Categories for OPTICROM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AllerganOPTICROMcromolyn sodiumSOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: OPTICROM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AllerganOPTICROMcromolyn sodiumSOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984► Subscribe► Subscribe
AllerganOPTICROMcromolyn sodiumSOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984► Subscribe► Subscribe
AllerganOPTICROMcromolyn sodiumSOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984► Subscribe► Subscribe
AllerganOPTICROMcromolyn sodiumSOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984► Subscribe► Subscribe
AllerganOPTICROMcromolyn sodiumSOLUTION/DROPS;OPHTHALMIC018155-001Oct 3, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Healthtrust
Citi
Express Scripts
Johnson and Johnson
Merck
UBS
Moodys
Harvard Business School
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot